Targeted mutagenesis of the Vibrio fischeri flavin reductase FRase I to improve activation of the anticancer prodrug CB1954 von Swe, P.M., Copp, J.N., Green, L.K., Guise, C.P., Mowday, A.M., Smaill, J.B., Patterson, A.V., Ackerley, D.F.

Volltext

474 POSTER Relationships between reductive metabolism, DNA crosslinks and antitumor activity of the hypoxia-activated prodrug PR-104 in preclinical models von Singleton, R.S, Pullen, S.M, Ferry, D.M, Guise, C.P, Patterson, A.V, Wilson, W.R

Volltext

473 POSTER The bioreductive prodrug PR-104 is activated under aerobic conditions by human aldo-keto reductase 1C3 (prostaglandin F synthase) von Patterson, A.V, Guise, C.P, Abbattista, M, van Leeuwen, W, Pullen, S.M, Ferry, D.M, Denny, W.A, Guilford, P, Wilson, W.R

Volltext

Laparoscopic Donor Nephrectomy: Effects of Learning Curve on Surgical Outcomes von Martin, G.L, Guise, A.I, Bernie, J.E, Bargman, V, Goggins, W, Sundaram, C.P

Volltext

Polarized ep collisions as probes for CP violation from beyond the standard model von ANGLIN, J, BURGESS, C. P, DE GUISE, H, MANGIN, C, ROBINSON, J. A

Volltext